0001861657
EX-FILING FEES
0001861657
2025-10-17
2025-10-17
0001861657
1
2025-10-17
2025-10-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Tables
FORM
S-3
(Form
Type)
THARIMMUNE,
INC.
(Exact
Name of Registrant as Specified in its Charter)
Table
1: Newly Registered Securities
| | |
Security Type | |
Security Class
Title | |
Fee Calculation Rule | |
Amount
Registered (2) | |
Proposed Maximum
Offering Price Per
Share | |
Maximum
Aggregate
Offering Price | | |
Fee Rate | |
Amount of
Registration Fee | |
| Fees to Be Paid | |
Equity | |
Common Stock, par value $0.0001 per share | |
Other (1) | |
326,750 (3) | |
$ | 2.89 | |
$ | 944,308 | | |
$ | 0.00013810 | | |
$ | 131 | |
| Fees Previously Paid | |
| |
| |
| |
| |
| | |
| | | |
| | | |
| | |
| Total
Offering Amounts | |
$ | 944,308 | | |
| | | |
$ | 131 | |
| Total
Fees Previously Paid | |
| | | |
| | | |
| - | |
| Total Fee Offsets | |
| | | |
| | | |
| - | |
| Net
Fee Due | |
| | | |
| | | |
$ | 131 | |
(1)
Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of
1933, as amended (the “Securities Act”), based upon the average of the high and low prices for a share of the registrant’s
common stock as reported on The Nasdaq Capital Market on October 13, 2025.
(2) Pursuant to Rule 416 under the Securities Act, the shares of common stock offered hereby also include an indeterminate number of additional
shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions.
(3)
Represents the resale of (i) 39,573 shares of our common stock issuable upon exercise of the warrants issued in connection with a private
placement in June 2024, (ii) 57,687 shares of our common stock issuable upon exercise of the warrants issued in connection with a private
placement in December 2024, (iii) 118,243 shares of our common stock issuable upon exercise of the Series A warrants issued in connection
with the private placement in June 2025, (iv) 59,119 shares of our common stock issuable upon exercise of the Series B warrants issued
in connection with a private placement in June 2025 and (v) 52,128 shares of our common stock issuable upon exercise of the warrants.
N/A